Business Wire

Dimension Data Introduces Next-Generation Managed Services Offering to Accelerate Client Innovation

Share

Dimension Data, a leading global technology integrator and managed services provider for hybrid IT, has today announced the launch of its next-generation global managed services to help clients simplify the management and operation of their technology.

Dimension Data’s Managed Services Platform now offers near real-time insight and reporting, managing over 9,000 IP networks and supporting over 13 million users across the globe. Meeting increasing client demands, the platform liberates IT and operations teams to focus on more strategic, value-add tasks such as improving the customer experience, maximising cost efficiencies, and exploring emerging technologies.

As Christian Saldias, IT Manager at ALMA, a Dimension Data Managed Services customer, explains: “We chose Dimension Data because our main core business is not IT, it’s scientific data production. We are a small IT team and we need support from a company that has all the expertise that we don’t have. Dimension Data provides us with all the expertise we don’t have – and we don’t need to have.”

Adapting to the elevated needs of the digital world has left IT teams relying on complex IT estates to meet rapidly shifting consumer demands. These often disparate, multi-vendor setups with public, private, and hybrid cloud aspects all need to be constantly maintained and managed.

This means there is often a reliance on already stretched IT teams with a lack of resources, which is hampering the efforts of many B2B IT support operations attempting to digitally transform.1 It also prompts security concerns, as businesses fear they do not possess the adequate in-house skills/resources to defend against incoming threats.2

Dimension Data’s approach to managed services builds on its proven track record of managing and integrating multi-vendor solutions by bringing together its cross-technology portfolio of managed services, delivered through a single scalable and secure platform.

The benefits of Dimension Data’s managed services offering include:

  • Next-generation automation capabilities – Access to comprehensive analytics, service delivery, and process development – along with proactive, near real-time performance visibility and control. The new award-winning Manage Centre portal provides a complete view of an IT estate’s performance.
  • Leading-edge agility and scalability – The ability to scale in rapid business growth environments with minimised risk of downtime, while unlocking end-to-end management and visibility across multi-vendor and multi-technology infrastructures.
  • Industry-defining client experience – Dedicated client success managers to help adoption and fast response resolution, also providing continuous support for improvement and innovation – as well as the ability to tap into the expertise and capability of industry-leading experts.
  • Cross-technology expertise – Deep expertise across multiple technology areas including networking, collaboration, security, customer experience and enterprise applications leveraging strong global partnerships with leading technology vendors.

Bill Padfield, Group COO of Transformation and Services at Dimension Data, commented: “Our global managed services and delivery platform has re-engineered the end-to-end client journey, radically simplifying IT operations management and eliminating the pressure of day-to-day operations, while also allowing clients to take advantage of Dimension Data’s relationship with other NTT companies and best-of-breed solution providers.”

About Dimension Data
Founded in 1983, Dimension Data is a USD 8 billion global leader in designing, optimising, and managing today’s evolving technology environments. This enables its clients to leverage data in a digital age, turn it into information, and extract insights. Headquartered in Johannesburg, Dimension Data employs 28,000 people across 47 countries. The company brings together the world’s best technology provided by market leaders and niche innovators with the service support that clients need for their businesses – from consulting, technical, and support services to a fully-managed service.

Dimension Data is a proud member of the NTT Group. Visit us at http://www.dimensiondata.com.

1 http://www.dimensiondata.com/insights/customer-experience-benchmarking-report-2019?utm_source=PressRelease&utm_medium=Referral&utm_campaign=CXBR2019&utm_content=CXBR2019Homepage&utm_SFDC_CampaignID=701D00000014fga
2 https://www.nttsecurity.com/en-uk/landing-pages/risk-value-2018

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Enquiries:
Stephanie Ross
Media Relations Manager (Group)
T: +44 (0)1252 779 122
M: +44 (0)783 336 2911
E: stephanie.ross@dimensiondata.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 Data for Incyte’s Retifanlimab (Zynyz ® ) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 01:45:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer (SCAC) who have not been previously treated with systemic chemotherapy, were published in The Lancet.1 “The publication of the POD1UM-303/InterAACT 2 trial in The Lancet is a testament to the strength of the data generated for retifanlimab in patients with inoperable locally recurrent or metastatic SCAC, a disease which until recently had seen limited innovation for decades,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “SCAC can be a devastating disease, and patients often have a poor prognosis. These data supported the U.S. Food and Drug Administration (FDA) approval of Zynyz® (retifanl

Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 22:30:00 EEST | Press release

Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal, but a core driver of innovation. Key milestones include a near-complete transition to natural refrigerants

Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 21:45:00 EEST | Press release

Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of European enterprises, providing a framework for high performance in even the most complex, secure environments. “With about 6 million developers across Europe, users deserve infrastructure that meets them where they are,” said Varun Mohan, CEO of Windsurf. “The demand for secure AI-powered development is undeniable and by launching this GPU cluster, we aim to b

Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 20:00:00 EEST | Press release

Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization journey, allowing developers to focus on building engaging games, not commerce infrastructure. This SDK connects three

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 18:00:00 EEST | Press release

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye